Identified prognostic subsets in metastatic rhabdomyosarcoma to guide experimental treatment candidate selection.
This analysis identified subsets of patients with metastatic rhabdomyosarcoma with different outcomes to current therapy and offers a strategy to define patient candidates for experimental approaches to treatment.
Oberlin et al. (2008) studied this question.